Oklahoma City Zofran Lawsuit Information for Birth Defect and Heart Defect Claims - Current Information About Oklahoma City Zofran Lawsuits from National Attorneys

Oklahoma City women and families whose baby developed birth defects or heart defects after being exposed to Zofran in utero have filed Oklahoma City Zofran birth defects lawsuits against the pharmaceutical giant GlaxoSmithKline. Plaintiffs in Oklahoma City Zofran birth defects lawsuits contest they were not warned about the risk of birth defects from Zofran use during pregnancy. Furthermore, Oklahoma City Zofran birth defect lawsuits aim to hold GlaxoSmithKline accountable for marketing Zofran for pregnant women even though this use has never been approved by the FDA, endangering fetuses and women, say plaintiffs in Oklahoma City Zofran lawsuits. Birth defects including physical deformities, cleft palate, and heart defects have all been linked to first trimester Zofran exposure.

Oklahoma City Zofran Heart Defects Lawsuits

For Oklahoma City families whose baby suffered heart defects after being exposed to Zofran in utero, you may qualify to file a Oklahoma City Zofran heart defect lawsuit to recover compensation for damages you and your family have suffered. Filing a Oklahoma City Zofran lawsuit serves two purposes:

First, filing a lawsuit can achieve financial compensation for your family for the suffering, damages, loss, and medical expenses encountered due to Zofran birth defects. Studies show that fetuses exposed to Zofran face a higher risk for heart defects and other physical abnormalities.

Second, a critical mass of Zofran birth defects lawsuits may be the most effective way for individual consumers in Oklahoma City and around the nation to exert pressure on a corporate giant to take responsibility for the safety of its products. Oklahoma City Zofran birth defect lawsuit claims may join forces in a Multi-District Litigation (MDL), uniting individual consumers to advance justice and safeguard others against the same danger in the future.

Our lawyers handling Zofran heart defect lawsuits in Oklahoma City offer free case review with no further obligation. Complete our simple contact form at the right of your screen and one of our attorneys handling Oklahoma City pharmaceutical claims will respond promptly. We are happy to provide information about Oklahoma City Zofran heart defect lawsuit time limits that apply to Oklahoma City, discuss your situation in detail with you, and answer your questions as definitively as possible.

Oklahoma City Zofran Birth Defect Lawsuits Are Not Class Action Lawsuits

Zofran birth defects lawsuits in Oklahoma City will not be class action lawsuits where those filing a claim can expect to receive only very small settlements. Although Oklahoma CityZofran birth defect lawsuits will likely become a Multi-District Litigation (MDL), each Oklahoma City Zofran lawsuit claim will be handled on its own merit and each plaintiff will receive compensation in accordance with the individual damages they suffered. MDL is a legal procedure that expedites cases that share a common injury among many plaintiffs across the country, while preserving details of individual cases to ensure fair compensation.

Oklahoma City Zofran Birth Defect Lawsuits: No Fees Unless We Collect for You

We will represent all persons involved in a Oklahoma City Zofran birth defect lawsuit for on a contingency basis, meaning our attorneys charge never charge any legal fees unless we win compensation in your case. For a free no-obligation consultation please fill out our short online contact form and one of our Oklahoma City Zofran heart defect lawyers will contact you to answer any of your questions.

No-Cost, No-Obligation Oklahoma City Zofran Birth Defect Lawsuit Case Review If You or a Loved One Has Had a Baby with Birth Defects in Oklahoma City

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit www.OnderLaw.com or call 1-877-ONDER-LAW.